Astrocyte Senescence as a Component of Alzheimer’s Disease
Open accessThe DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.
Abstract
Aging is the main risk factor for Alzheimer's disease (AD); however, the aspects of the aging process that predispose the brain to the development of AD are largely unknown. Astrocytes perform a myriad of functions in the central nervous system to maintain homeostasis and support neuronal function. In vitro, human astrocytes are highly sensitive to oxidative stress and trigger a senescence program when faced with multiple types of stress. In order to determine whether senescent astrocytes appear in vivo, brain tissue from aged individuals and patients with AD was examined for the presence of senescent astrocytes using p16(INK4a) and matrix metalloproteinase-1 (MMP-1) expression as markers of senescence. Compared with fetal tissue samples (n = 4), a significant increase in p16(INK4a)-positive astrocytes was observed in subjects aged 35 to 50 years (n = 6; P = 0.02) and 78 to 90 years (n = 11; P<10(-6)). In addition, the frontal cortex of AD patients (n = 15) harbored a significantly greater burden of p16(INK4a)-positive astrocytes compared with non-AD adult control subjects of similar ages (n = 25; P = 0.02) and fetal controls (n = 4; P<10(-7)). Consistent with the senescent nature of the p16(INK4a)-positive astrocytes, increased metalloproteinase MMP-1 correlated with p16(INK4a). In vitro, beta-amyloid 1-42 (Aβ(1-42)) triggered senescence, driving the expression of p16(INK4a) and senescence-associated beta-galactosidase. In addition, we found that senescent astrocytes produce a number of inflammatory cytokines including interleukin-6 (IL-6), which seems to be regulated by p38MAPK. We propose that an accumulation of p16(INK4a)-positive senescent astrocytes may link increased age and increased risk for sporadic AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In many prevalent neurodegenerative conditions including Alzheimer's Disease, brain tissue biopsies are present with increased levels of p16INK4a- positive astrocytes, MMP-1 and IL-6”
From Redox control of senescence and age-related disease. (2017) · cites this paper as [99]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Astrocytes cultured from patients with AD express not only more of the CDKi p16 INK4A than age-matched controls, but also more MMP1 and IL-6 (57).”
From Cellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives (2018) · cites this paper as [57]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Previous studies have highlighted senescence in multiple brain cell types in AD [3, 16, 32, 52, 80].”
From Characterisation of premature cell senescence in Alzheimer's disease using single nuclear transcriptomics (2024) · cites this paper as [3]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In the context of aging and neurodegenerative disease, senescent cell accumulation has been identified in multiple cell types within the central nervous system (CNS), including neurons6,7,14,15, astrocytes16,17, microglia8,18, oligodendrocyte precursor cells19 and endothelial cells20.”
From Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial (2023) · cites this paper as [16]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Furthermore, prior research conducted on postmortem brain tissue from individuals with AD has identified senescent astrocytes16, and mouse models have demonstrated that they are cleared with senolytic treatment8,17.”
From Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial (2023) · cites this paper as [16]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 1×
“Staining for Senescence-associated b-galactosidase Senescence-associated beta-galactosidase (SA b-gal) staining was performed as previously described [62].”
MethodThe senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206 · cited 11×
“One component of the SASP present in multiple cell types is IL-6.”
BackgroundInfluentialAstrocytes: Biology and pathology
Sofroniew, M. V., & Vinters, H. V. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0619-8 · Cited by 5,196 · cited 1×
“Astrocytes regulate the contents of the synaptic cleft and synaptic transmission as part of the tripartite synapse, control CNS metabolism, and maintain blood brain barrier integrity [10,11].”
BackgroundWalsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291 · cited 1×
“The increased dosage of synthetic versus cell-derived Ab oligomers required to trigger senescence, correlates with reports on the effects of Ab on rat hippocampal long-term potentiation [53].”
BackgroundShankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 1×
“demonstrated by the phenotypic improvement observed following the targeted removal of senescent cells in a progeroid mouse model [9].”
BackgroundInfluentialMechanisms underlying inflammation in neurodegeneration
Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010) · Cell · doi:10.1016/j.cell.2010.02.016 · Cited by 3,580 · cited 1×
“In vitro, we found that exposure of astrocytes to Ab1–42 triggers senescence and that senescent astrocytes produce high quantities of interleukin-6 (IL-6), a cytokine known to be increased in the CNS of AD patients [18].”
Background2013 Alzheimer's disease facts and figures
Alzheimer's Association, Thies, W., & Bleiler, L. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.02.003 · Cited by 3,328
Alzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census
Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., & Evans, D. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1119 · Cited by 2,168 · cited 1×
“We selected the age ranges of 35–50 years and 78–90 years (Figure 3B) in order to compare a group that is least likely to have AD and a group that is most likely to have AD [31].”
MethodBRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Cited by
Items 201–300 of 589
Reactive gliosis in Alzheimer’s disease: a crucial role for cognitive impairment and memory loss
Sousa, R. A. L. D. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-00953-2 · Cited by 56
Bang, M., Kim, D. G., Gonzales, E. L., Kwon, K. J., & Shin, C. Y. (2019) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2019.151 · Cited by 46
“In the brains of Alzheimer’s disease patients as well as in aged subjects, increased expression of senescent astrocytes as well as changes in astrocyte morphology has been reported (Bhat et al., 2012).”
BackgroundMethodInfluentialJi, J., Ding, K., Cheng, B., Zhang, X., Luo, T., Huang, B., Hao, Y., Chen, Y., Xu, X., Lin, H., et al. (2024) · Advanced Science · doi:10.1002/advs.202304609 · Cited by 60
Aging, cellular senescence and Parkinson's disease
Ma, Y., Erb, M. L., & Moore, D. J. (2025) · Journal of Parkinson s Disease · doi:10.1177/1877718x251316552 · Cited by 59
Cellular Senescence, Neurological Function, and Redox State
Maciel-Barón, L. Á., Moreno-Blas, D., Morales-Rosales, S. L., González-Puertos, V. Y., López-Díazguerrero, N. E., Torres, C., Castro-Obregón, S., & Königsberg, M. (2018) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7112 · Cited by 45
“Senescent cells have recently been observed in CNS (11, 13, 35), so understanding their participation is very important to comprehend brain deterioration during aging as well as the progression of various NDDs.”
InfluentialSelf-citationThe role of cellular senescence in aging through the prism of Koch-like criteria
Yanai, H., & Fraifeld, V. E. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2017.10.004 · Cited by 45
From Metabolic Syndrome to Neurological Diseases: Role of Autophagy
Maiuolo, J., Gliozzi, M., Musolino, V., Carresi, C., Scarano, F., Nucera, S., Scicchitano, M., Bosco, F., Ruga, S., Zito, M. C., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.651021 · Cited by 55
“Astrocytes are very susceptible to oxidative stress and inflammation; becoming unable to perform their role of maintaining ions and neurotransmitters in physiological conditions for BBB integrity (Bhat et al., 2012).”
BackgroundJohnson, R. J., Tolan, D. R., Bredesen, D. E., Nagel, M. A., Sánchez‐Lozada, L. G., Fini, M. A., Burtis, S., Lanaspa, M. A., & Perlmutter, D. (2023) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2023.01.002 · Cited by 53
Fan, L., Qiu, X., Zhu, Z., Lv, J., Lu, J., Mao, F., Zhu, J., Wang, J., Guan, X., Chen, J., et al. (2019) · Acta Pharmacologica Sinica · doi:10.1038/s41401-019-0220-1 · Cited by 47
Mechanistic complexities of bone loss in Alzheimer’s disease: a review
Frame, G., Bretland, K. A., & Dengler-Crish, C. M. (2020) · Connective Tissue Research · doi:10.1080/03008207.2019.1624734 · Cited by 44
Drainage of senescent astrocytes from brain via meningeal lymphatic routes
Li, Q., Chen, Y., Feng, W., Cai, J., Gao, J., Ge, F., Zhou, T., Wang, Z., Ding, F., Marshall, C., et al. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.04.005 · Cited by 47
Sandau, U. S., McFarland, T. J., Smith, S. J., Galasko, D. R., Quinn, J. F., & Saugstad, J. A. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.864022 · Cited by 42
“In a study using AD brains, immunostaining showed the accumulation of senescent astrocytes (Bhat et al., 2012).”
BackgroundSaha, P., & Biswas, S. C. (2015) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2015.08.002 · Cited by 43
“…Ca++ influx, oxidative stress, NO production, mitochondrial dysfunction, ER stress and caspase activation (Smale et al., 1995; Takuma et al., 1999; Lewen et al., 2000; Takuma et al., 2001; Sanchez et al., 2003; Alano et al., 2004; Bonini et al., 2004; Giffard & Swanson, 2005; Bhat et al., 2012).”
BackgroundNie, X., Liang, L., Xi, H., Jiang, S., Jiang, J., Tang, C., Liu, X., Liu, S., Wan, C., Zhao, J., et al. (2015) · Journal of Applied Toxicology · doi:10.1002/jat.3084 · Cited by 43
“Wiley & Sons, Ltd. 1 852 Accumulation of aging astrocytes may be an age-related risk factor for AD (Alzheimer’s disease) (Bhat et al., 2012).”
BackgroundConnecting chaperone-mediated autophagy dysfunction to cellular senescence
Moreno-Blas, D., Gorostieta-Salas, E., & Castro‐Obregón, S. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.11.001 · Cited by 46
The need to incorporate aged animals into the preclinical modeling of neurological conditions
Sun, M., McDonald, S. J., Brady, R. D., Collins‐Praino, L. E., Yamakawa, G. R., Monif, M., O'Brien, T. J., CLOUD, G. C., Sobey, C. G., Mychasiuk, R., et al. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.12.027 · Cited by 50
Shokhirev, M. N., & Johnson, A. A. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101721 · Cited by 42
Circular RNAs : emerging players in brain aging and neurodegenerative diseases
Wu, D., Zhao, Y., Yan, Q., Liu, L., Wei, Y., & Huang, J. (2022) · The Journal of Pathology · doi:10.1002/path.6021 · Cited by 44
Cellular senescence and the blood–brain barrier: Implications for aging and age-related diseases
Knopp, R. C., Erickson, M. A., Rhea, E. M., Reed, M. J., & Banks, W. A. (2023) · Experimental Biology and Medicine · doi:10.1177/15353702231157917 · Cited by 48
Iba, M., Kim, C., Kwon, S., Szabo, M. P., Horan-Portelance, L., Peer, C. J., Figg, W. D., Reed, X., Ding, J., Lee, S., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abq6089 · Cited by 43
Zheng, L., He, S., Wang, H., Li, J., Liu, Y., & Liu, S. (2024) · Aging and Disease · doi:10.14336/ad.2024.0206 · Cited by 83
“Also, induction of primary cultured astrocytes with Aβ1-42 in vitro was found to cause senescence in a concentration-dependent manner [105].”
Marino, J., Wigdahl, B. L., & Nonnemacher, M. R. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00168 · Cited by 44
Hou, J., Kim, S., Sung, C., & Choi, C. (2017) · Molecules · doi:10.3390/molecules22091516 · Cited by 41
“Interestingly, β-amyloid peptide also stimulates chemokine expression, the secretion of ROS and cytokines from rat astrocytes [14].”
BackgroundGuo, X., Lv, J., Lu, J., Fan, L., Huang, X., Hu, L., Wang, J., & Shen, X. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.11.033 · Cited by 41
“Reagents and conditions: a) Dess-martin priodinane, CH2Cl2, 0 C; b) NH2OH$HCl, CH3ONa, rt; c) NaBH3CN, NH4OAc, TiCl3, CH3OH, d) 3,4-dimethoxyphenethyl isocyanate, TEA, DCM, rt, 3h. suitable model for the related assays (Bhat et al., 2012; Groemer et al., 2011; Guenette, 2003).”
The influence of immunological stressors on traumatic brain injury
Sun, M., McDonald, S. J., Brady, R. D., O'Brien, T. J., & Shultz, S. R. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.01.007 · Cited by 44
β-Catenin and TCFs/LEF signaling discordantly regulate IL-6 expression in astrocytes
Robinson, K. F., Narasipura, S. D., Wallace, J., Ritz, E. M., & Al‐Harthi, L. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00565-2 · Cited by 45
Hydrogen sulfide in longevity and pathologies: Inconsistency is malodorous
Sokolov, A. S., Nekrasov, P. V., Shaposhnikov, M. V., & Moskalev, A. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101262 · Cited by 45
Garwood, C. J., Simpson, J. E., Al Mashhadi, S., Axe, C., Wilson, S., Heath, P. R., Shaw, P. J., Matthews, F. E., Brayne, C., Ince, P. G., et al. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12156 · Cited by 39
Bouvier, D. S., Fixemer, S., Heurtaux, T., Jeannelle, F., Frauenknecht, K. B. M., & Mittelbronn, M. G. A. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.814889 · Cited by 47
Wong, G. C., & Chow, H. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220203 · Cited by 48
Wang, S., Li, B., Li, J., Cai, Z., Hugo, C., Sun, Y., Qian, L., TCW, J., Chui, H. C., Dikeman, D., et al. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00802-7 · Cited by 39
“Amyloid beta (Aβ) and tau accumulation are major inducers of cellular senescence in AD [11, 62], and the removal of senescent cells has been shown to alleviate AD pathology and enhance memory in AD mouse models [12, 13].”
Aging, the Metabolic Syndrome, and Ischemic Stroke
Lucke-Wold, B. P., Logsdon, A. F., Turner, R. C., Rosen, C. L., & Huber, J. D. (2014) · Advances in pharmacology · doi:10.1016/bs.apha.2014.07.001 · Cited by 48
“Much like neurons, astrocytes are subject to agerelated burdens, such as oxidative stress (Brera, Serrano, & de Ceballos, 2000; Niranjan, 2013) and telomeric replication exhaustion (Bhat et al., 2012; Bitto et al., 2010).”
BackgroundHo, D. H., Seol, W., & Son, I. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1577666 · Cited by 39
“The SASP factors, matrix metalloproteinase 3 and p16, are induced in the astrocytes of aged human brain tissue in autopsied and cortical brain tissue of patientswithAlzheimer’s disease (AD) compared to age-matched controls [22].”
BackgroundA guide to senolytic intervention in neurodegenerative disease
Lee, S., Wang, E. Y., Steinberg, A. B., Walton, C. C., Chinta, S. J., & Andersen, J. K. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111585 · Cited by 39
Sex Differences in Astrocyte Activity
Gozlan, E., Lewit-Cohen, Y., & Frenkel, D. (2024) · Cells · doi:10.3390/cells13201724 · Cited by 51
“Sex differences in astrocytes can be observed from morphology to gene expression and activity.”
BackgroundA Model for p38MAPK-Induced Astrocyte Senescence
Mombach, J. C. M., Vendrusculo, B., & Bugs, C. A. (2015) · PLOS ONE · doi:10.1371/journal.pone.0125217 · Cited by 38
“Pharmacological inhibition of p38MAPK in pre-senescent and senescent human astrocytes prevents SASP [9], while the effect of its GoF is yet unknown.”
BackgroundInfluentialResidual Disease in Glioma Recurrence: A Dangerous Liaison with Senescence
Putavet, D. A., & de Keizer, P. L. J. (2021) · Cancers · doi:10.3390/cancers13071560 · Cited by 45
“First, aged brains from healthy individuals over the age of 60 are abundant in senescent astrocytes, and GBM is mostly diagnosed in this age group (Figure 2) [28].”
BackgroundInfluentialAge-Related Midbrain Inflammation and Senescence in Parkinson’s Disease
Russo, T., & Rießland, M. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.917797 · Cited by 40
“Further support for a role of astrocyte senescence in neurodegeneration comes from AD research, where senescent astrocytes have been observed in AD and have been shown to be triggered by β-amyloid and to produce inflammatory cytokines (Bhat et al., 2012).”
BackgroundMetabolic Dysfunction of Astrocyte: An Initiating Factor in Beta-amyloid Pathology?
Yan, L., Xiao, M., Chen, R., & Cai, Z. (2013) · PubMed · Cited by 44
González‐Giraldo, Y., Forero, D. A., Echeverría, V., González, J., Ávila-Rodriguez, M., García‐Segura, L. M., & Barreto, G. E. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.04.004 · Cited by 45
Bcl-xL as a Modulator of Senescence and Aging
Mas‐Bargues, C., Borrás, C., & Viña, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041527 · Cited by 41
“In mouse models, the SASP has been associated with several age-related diseases such as atherosclerosis [76], sarcopenia [86], Alzheimer’s disease [70], cataracts [87] and intervertebral disc degeneration [88].”
BackgroundMolecular Mechanisms of Cellular Senescence in Neurodegenerative Diseases
Lee, H.-J., Yoon, Y.-S., & Lee, S.-J. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168114 · Cited by 36
SIPS as a model to study age-related changes in proteolysis and aggregate formation
Ott, C., Jung, T., Grune, T., & Höhn, A. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.07.007 · Cited by 44
The Interaction of miR-378i-Skp2 Regulates Cell Senescence in Diabetic Nephropathy
Tsai, Y., Kuo, P., Kuo, M., Hung, W., Wu, L., Chang, W., Wu, P., Lee, S., Chen, H., & Hsu, Y. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7120468 · Cited by 38
“SASP has played a principal role in tissue microenvironments of renal pathophysiology and it provides biological signal transduction in neighboring cells [30].”
BackgroundLi, X., Lu, J., Xu, Y., Wang, J., Qiu, X., Fan, L., Li, B., Liu, W., Mao, F., Zhu, J., et al. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.07.006 · Cited by 40
“(3r,5r,7r)-N-(5-Morpholinothiazol-2-yl)adamantane-1carboxamide (44) 44 was synthesized by the general procedure of 24 given above, benzoyl chloride was replaced by 1-adamantanecarbonyl chloride, to afford 44 as a white solid.”
MethodA geroscience motivated approach to treat Alzheimer’s disease: Senolytics move to clinical trials
Gonzales, M. M., Krishnamurthy, S., Garbarino, V. R., Daeihagh, A. S., Gillispie, G. J., Deep, G., Craft, S., & Orr, M. E. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111589 · Cited by 38
Ristori, S., Bertoni, G., Bientinesi, E., & Monti, D. (2025) · Nutrients · doi:10.3390/nu17111837 · Cited by 45
“Evidence shows that senescent astrocytes accumulate in AD and PD patients, promoting inflammation through the SASP factors [40–42].”
Biomarkers in the path from cellular senescence to frailty
Zampino, M., Ferrucci, L., & Semba, R. D. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.110750 · Cited by 42
Ting, K. K., Coleman, P. R., Zhao, Y., Vadas, M. A., & Gamble, J. R. (2021) · Vascular Biology · doi:10.1530/vb-20-0013 · Cited by 43
Cellular senescence and neurodegeneration
Holloway, K., Neherin, K., Dam, K., & Zhang, H. (2023) · Human Genetics · doi:10.1007/s00439-023-02565-x · Cited by 33
Preininger, M. K., Zaytseva, D., Lin, J. M., & Kaufer, D. (2023) · Aging Cell · doi:10.1111/acel.13747 · Cited by 36
“Therefore, p-p38MAPK has been used as an additional indicator of senescence in astrocytes (Bhat et al., 2012; Mombach et al., 2015) and neurons (Jurk et al.”
BackgroundMethodInfluentialOld Stars and New Players in the Brain Tumor Microenvironment
Parmigiani, E., Scalera, M., Mori, E., Tantillo, E., & Vannini, E. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.709917 · Cited by 35
Li, Y., Lü, J., Hou, Y., Huang, S., & Pei, G. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.906270 · Cited by 41
Diwan, B., & Sharma, R. (2022) · Food Science and Biotechnology · doi:10.1007/s10068-022-01114-y · Cited by 40
“As SC accumulate in tissues and organs, the chronic presence of SASP becomes increasingly detrimental as it affects nearby healthier cells through paracrine effects resulting in pro-inflammatory and pro-tumorigenic environment (Birch and Gil, 2020).”
BackgroundInfluentialLi, C., Guo, X., Lei, M., Wu, J., Jin, J.-Z., Shi, X., Zhu, Z., Rukachaisirikul, V., Hu, L., Wen, T., et al. (2016) · Acta Pharmacologica Sinica · doi:10.1038/aps.2016.94 · Cited by 36
Diniz, B. S., Vieira, E. M., Mendes‐Silva, A. P., Bowie, C. R., Butters, M. A., Fischer, C. E., Flint, A., Herrmann, N., Kennedy, J., Lanctôt, K. L., et al. (2021) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1002/trc2.12129 · Cited by 33
Matias, I. C. P., Diniz, L. P., Araújo, A. P. B., Damico, I. V., de Moura, P., Cabral‐Miranda, F., Diniz, F., Parmeggiani, B., Coelho, V. D. M., Leite, R. E. P., et al. (2023) · ASN NEURO · doi:10.1177/17590914231157974 · Cited by 38
“…aging, the increasing number of senescent cells, including glial cells, has been linked to the chronic inflammation observed in advanced age (Salminen et al., 2011) and neurodegeneration in both animal models and AD and PD human brain (Bhat et al., 2012; Bussian et al., 2018; Chinta et al., 2018).”
BackgroundWang, J., Lu, Y., Carr, C., Dhandapani, K. M., & Brann, D. W. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1227705 · Cited by 44
“, 2019), as well as in the aging and AD brain (Bhat et al., 2012; Bussian et al., 2018; Ogrodnik et al., 2021).”
BackgroundSenescent Microglia Represent a Subset of Disease-Associated Microglia in P301S Mice
Ng, P. Y., Zhang, C., Li, H., & Baker, D. J. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230109 · Cited by 41
“Several cell types have been proposed to become senescent in age-related neurodegenerative diseases, including microglia [9, 12, 13], astrocytes [9, 10, 14], neurons [15–17], and oligodendrocyte progenitor cells [8].”
Senolytic treatment for low back pain
Mannarino, M., Cherif, H., Darband, S. G., Martinez, O. W., Sheng, K., Cousineau, E., Lee, S., Millecamps, M., Gao, C., Gilbert, A., et al. (2025) · Science Advances · doi:10.1126/sciadv.adr1719 · Cited by 39
“An accumulation of SnCs has been reported in neurons ( 74 , 76 , 121 ), glial cells ( 73 , 76 , 77 , 122 – 124 ), and astrocytes ( 125 – 129 ) in humans and animals with pain.”
The Hallmarks of Ageing in Microglia
Carr, L. M., Mustafa, S., & Collins‐Praino, L. E. (2025) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01564-y · Cited by 42
Cellular senescence and failure of myelin repair in multiple sclerosis
Koutsoudaki, P. N., Papadopoulos, D., Passias, P.-G., Koutsoudaki, P., & Gorgoulis, V. G. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111366 · Cited by 33
“Cellular senescence has also been shown to affect neurons, microglia, astrocytes, pericytes and endothelial cells (Bhat et al., 2012; Kiss et al., 2020; Safaiyan et al., 2016; Yamazaki et al., 2016), cell types which may directly or indirectly influence the efficiency of myelin repair.”
Álvarez, M., Rivas, L., Lacruz, C., & Toledano, A. (2015) · Glia · doi:10.1002/glia.22751 · Cited by 35
Pramotton, F. M., Spitz, S., & Kamm, R. D. (2024) · Advanced Science · doi:10.1002/advs.202403892 · Cited by 39
Maciel-Barón, L. Á., Morales-Rosales, S. L., Silva‐Palacios, A., Rodríguez‐Barrera, R., García, J. A., Luna‐López, A., Pérez, V., Torres, C. A., & Königsberg, M. (2018) · Biogerontology · doi:10.1007/s10522-018-9767-3 · Cited by 36
Self-citationThe far-reaching HAND of cART: cART effects on astrocytes
Gonzalez, H., Podany, A. T., Al‐Harthi, L., & Wallace, J. (2020) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-020-09907-w · Cited by 36
Role of the Wnt pathway in the formation, development, and degeneration of intervertebral discs
Wu, Z., Xie, Q.-Q., Liu, T.-C., Yang, X., Zhang, G., & Zhang, H. (2021) · Pathology - Research and Practice · doi:10.1016/j.prp.2021.153366 · Cited by 32
Contribution of senescent and reactive astrocytes on central nervous system inflammaging
López‐Teros, M., Alarcón‐Aguilar, A., López‐Díazguerrero, N. E., Luna‐López, A., & Königsberg, M. (2022) · Biogerontology · doi:10.1007/s10522-022-09952-3 · Cited by 39
“…of senescent astrocytes can generate neuroinflammation and contribute to neurodegenerative disorders (Bitto et al. 2010; Di Malta et al. 2012; Bhat et al. 2012; Chinta et al. 2018; Guerrero et al. 2021), where the SASP negatively impacts the structure, function, and metabolism of the brain…”
BackgroundMiller, S., Campbell, C. E., Jimenez-Corea, H. A., Wu, G., & Logan, R. A. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.824191 · Cited by 38
“Normal aging gives rise to astrocytic senescence-inducing factors such as damaged DNA and shortened telomeres (Bhat et al., 2012; Kang et al., 2015).”
BackgroundSenescence and SASP Are Potential Therapeutic Targets for Ischemic Stroke
Ouvrier, B., Ismael, S., & Bix, G. J. (2024) · Pharmaceuticals · doi:10.3390/ph17030312 · Cited by 38
“Neuronal senescence has been implicated in the pathogenesis of various neurodegenerative diseases [75].”
BackgroundKim, S. Y., & Cheon, J. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102446 · Cited by 36
Autophagy and Cellular Senescence in Alzheimer's Disease: Key Drivers of Neurodegeneration
Hussain, M. S., Agrawal, N., Ilma, B., Rekha, M. M., Nayak, P. P., Kaur, M., Khachi, A., Goyal, K., Rekha, A., Gupta, S., et al. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70503 · Cited by 37
Ha, T.-Y., Choi, Y. R., Noh, H. R., Cha, S., Kim, J.-B., & Park, S. M. (2021) · Molecular Brain · doi:10.1186/s13041-021-00834-2 · Cited by 34
Brain cellular senescence in mouse models of Alzheimer’s disease
Dorigatti, A. O., Riordan, R., Yu, Z., Ross, G., Wang, R., Reynolds-Lallement, N. C., Magnusson, K. R., Galván, V., & Pérez, V. (2022) · GeroScience · doi:10.1007/s11357-022-00531-5 · Cited by 35
“[19] provided strong evidence that astrocytes in brain tissue from aged individuals and patients with Alzheimer’s disease (AD) undergo senescence measured as a significant increase in p16INK4a and matrix metalloproteinase-1 (MMP-1) expression [19, 20].”
HIV antiretroviral therapy drugs induce premature senescence and altered physiology in HUVECs
Cohen, J., D’Agostino, L., Tuzer, F., & Torres, C. (2018) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2018.07.008 · Cited by 31
Self-citationConnecting the dots: Neuronal senescence, stress granules, and neurodegeneration
Ma, Y., & Farny, N. G. (2023) · Gene · doi:10.1016/j.gene.2023.147437 · Cited by 33
Chamoli, M., Chinta, S. J., & Andersen, J. K. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1887-z · Cited by 31
Anti-IL17 treatment ameliorates Down syndrome phenotypes in mice
Rueda, N., Vidal, V., García-Cerro, S., Narcís, J. O., Llorens-Martín, M., Corrales, A., Lantigua, S., Iglesias, M., Merino, J., Merino, R., et al. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.05.008 · Cited by 30
Low Dose Chronic Angiotensin II Induces Selective Senescence of Kidney Endothelial Cells
Khan, I., Schmidt, M. O., Kallakury, B., Jain, S. S., Mehdikhani, S., Levi, M., Mendonca, M., Welch, W. J., Riegel, A. T., Wilcox, C. S., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.782841 · Cited by 28
“Subsequently the understanding of the role of cellular senescence was expanded to the pathophysiology of Alzheimer’s Disease, Type 1 Diabetes, Pulmonary Fibrosis, Osteoarthritis, Cardiovascular and Kidney Disease (Bhat et al., 2012; Palmer et al., 2015; Jeon et al., 2017; Álvarez et al., 2017; Shimizu and Minamino, 20…”
BackgroundNanoparticles-based anti-aging treatment of Alzheimer’s disease
Chu, J., Ji, W., Zhuang, J., Gong, B., Chen, X., Cheng, W., Liang, W., Li, G., Gao, J., & Yin, Y. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2094501 · Cited by 33
“With the increase in age, the number of p16 Ink4a positive astrocytes increases in human brain tissue (Bhat et al., 2012).”
BackgroundVielee, S. T., & Wise, J. P. (2023) · Brain Sciences · doi:10.3390/brainsci13030500 · Cited by 35
“Further, the brain tissue of patients who suffered from early onset AD (ages 35–50) had significantly increased expression of p16INK4a in astrocytes, with a greater burden of increased p16INK4a expression in the prefrontal cortex, an area known to atrophy during AD progression [58,61].”
BackgroundInduction of a Senescence-Like Phenotype in Cultured Human Fetal Microglia During HIV-1 Infection
Chen, N. C., Partridge, A. T., Tuzer, F., Cohen, J., Nacarelli, T., Navas-Martín, S., Sell, C., Torres, C., & Martín-García, J. (2018) · The Journals of Gerontology: Series A · doi:10.1093/gerona/gly022 · Cited by 29
Self-citationGreenberg, E. F., Voorbach, M. J., Smith, A. G., Reuter, D. R., Zhuang, Y., Wang, J.-Q., Wooten, D., Asque, E., Hu, M., Hoft, C., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e36483 · Cited by 34
“Senescence and SASP contribute to multiple pathological features of neurological disorders, including proteostasis defects [16,17], neuroinflammation [18,19], dysfunctional mitochondria [20 – 22], and accumulation of misfolded proteins [18,19,23,24].”
BackgroundRole of Inflammasomes in HIV-1 and Drug Abuse Mediated Neuroinflammaging
Sil, S., Niu, F., Chivero, E. T., Singh, S., Periyasamy, P., & Buch, S. J. (2020) · Cells · doi:10.3390/cells9081857 · Cited by 29
Nuclear dynamics and stress responses in Alzheimer’s disease
Iatrou, A., Clark, E. M., & Wang, Y. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00489-6 · Cited by 34
“Mouse studies also provided evidence of senescent glia and neurons near Aβ plaques or NFTs, but the cell types undergoing senescence varied among animal models [141, 144, 145, 150, 151].”
BackgroundYang, Y., Seok, M., Kim, Y. E., Choi, Y., Song, J., Sulistio, Y. A., Kim, S., Chang, M., Oh, S., Nam, M., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01693-6 · Cited by 32
“effects by clearing senescent cells in AD model mice [58, 59, 61, 62].”
Role of astrocytic glycolytic metabolism in Alzheimer’s disease pathogenesis
Fu, W., & Jhamandas, J. H. (2014) · Biogerontology · doi:10.1007/s10522-014-9525-0 · Cited by 39
“cytokine release and other mediators of inflammation (Bhat et al. 2012).”
BackgroundThe Role of Kinase Modulators in Cellular Senescence for Use in Cancer Treatment
Lee, C. W., Baek, J., & Han, S. (2017) · Molecules · doi:10.3390/molecules22091411 · Cited by 31
“Cellular senescence is also thought to play a role in pathological processes, including liver fibrosis [44], renal fibrosis [45], cardiac fibrosis [46], vascular diseases (atherosclerosis) [47,48], metabolic diseases (obesity [49], type 2 diabetes [50]), neurological disorders (Alzheimer’s disease [51], Parkinson’s di…”
BackgroundLu, K.-J., Sheu, J., Teng, R.-D., Jayakumar, T., Chung, C., & Hsieh, C. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.84060 · Cited by 31
“[13] The senescence of neuronal cells can affect the pathophysiology of various neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease.[14] Removing senescent cells prevents gliosis, neurofibrillary tangle deposition, and the degeneration of cortical and hippocampal neurons, thereby preserving…”
Gut microbiota–astrocyte axis: new insights into age-related cognitive decline
Zhang, L., Wei, J., Liu, X., Li, D., Pang, X., Chen, F., Cao, H., & Lei, P. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01776 · Cited by 32
“Notably, Aβ 1–42 and extracellular tau exposure have been shown to induce senescence in astrocytes in vitro , and the expression levels of p16, senescence-associated beta-galactosidase, and SASP were increased (Bhat et al., 2012; Ungerleider et al., 2021).”
BackgroundFu, Y., Zhang, J., Qin, R., Ren, Y., Zhou, T., Han, B., & Liu, B. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100053 · Cited by 35
Zhou, Q., Luo, J., Chai, X., Yang, J., Zhong, S., Zhang, Z., Chang, X., & Wang, H. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114679 · Cited by 33
Alzheimer’s Disease: From Molecular Mechanisms to Promising Therapeutic Strategies
Ivanova, A. V., Kutuzova, A. D., Kuzmichev, I. A., & Abakumov, M. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199444 · Cited by 35
Hou, J., Yun, Y. J., Xue, J., Sun, M., & Kim, S. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10677 · Cited by 36
Garbarino, V. R., Palavicini, J. P., Melendez, J., Barthelemy, N. R., He, Y., Kautz, T. F., Lopez-Cruzan, M., Mathews, J. J., Xu, P., Zhang, B., et al. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00591 · Cited by 26
“…these dysfunctional cells and their accompanying pro-in fl ammatory senescence associated secretory phenotype (SASP) contribute to many age-associated pathogenic processes and diseases, including amyloid β (A β ) and tau pathologies of Alzheimer ’ s disease and related dementias (AD; ADRDs) [2 – 5].”
DNA damage as a marker of brain damage in individuals with history of concussions
Schwab, N., Tator, C., & Hazrati, L.-N. (2019) · Laboratory Investigation · doi:10.1038/s41374-019-0199-8 · Cited by 26
“The acquisition of a senescent cellular phenotype has been shown to create a chronic state of inflammation often seen in aged brains [64] and, in particular, senescent phenotypes have been reported as playing a role in the progression of neurodegenerative disease [65].”
BackgroundRevolutionizing Diabetic Foot Ulcer Care: The Senotherapeutic Approach
Zhang, G., Samarawickrama, P. N., Gui, L., Ma, Y., Cao, M., Zhu, H., Li, W., Yang, H., Li, K., Yang, Y., et al. (2024) · Aging and Disease · doi:10.14336/ad.2024.0065 · Cited by 32
“Recent studies [21, 79-81] have shown that cellular senescence is associated with diseases such as T2DM, Alzheimer's disease, Parkinson's disease, and chronic obstructive pulmonary disease, among others [82].”
Immunological biomarkers of aging
Wu, F., Mu, W., Markov, N. T., Fuentealba, M., Halaweh, H., Senchyna, F., Manwaring-Mueller, M., Winer, D. A., & Furman, D. (2025) · The Journal of Immunology · doi:10.1093/jimmun/vkae036 · Cited by 41
Unknown fates of (brain) oxidation or UFO: Close encounters with neuronal senescence
Walton, C. C., & Andersen, J. K. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.01.012 · Cited by 26
The chemotherapeutic agent doxorubicin induces brain senescence, with modulation by APOE genotype
Demby, T. C., Gross, P. S., Mandelblatt, J. S., Huang, J. K., & Rebeck, G. W. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114609 · Cited by 28
Metadata
- Authors
- Bhat, R., Crowe, E. P., Bitto, A., Moh, M., Katsetos, C. D., Garcia, F. U., Johnson, F. B., Trojanowski, J. Q., Sell, C., & Torres, C.
- Affiliations
- Drexel University (US)
- University of Pennsylvania (US)
- Corresponding author
- Torres, Claudio
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-09-12
- Volume
- 7
- Issue
- 9
- Pages
- e45069
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3440417
- OpenAlex
- W2026433865
- Cited by
- 586
- References
- 64
- Citations by year
- 2026: 44 · 2025: 56 · 2024: 68 · 2023: 54 · 2022: 52 · 2021: 59 · 2020: 53 · 2019: 47 · 2018: 37 · 2017: 27 · 2016: 31 · 2015: 17 · 2014: 30 · 2013: 7 · 2012: 3
- FWCI
- 12.23
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Drexel University
- National Institutes of Health
- University of California, San Diego
- College of Medicine, Drexel University
- National Institute on Aging (AG022443-S1, AG022443, R01AG022443)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- astrocyte senescence, Alzheimer's disease, aging, p16INK4a, MMP-1, amyloid-beta 42, oxidative stress, senescence-associated β-galactosidase, interleukin-6, p38 MAPK, neuroinflammation, frontal cortex, sporadic Alzheimer's disease
- MeSH terms
- Adult, Aged, Aged, 80 and over, Alzheimer Disease, Animals, Astrocytes, Brain, Cells, Cultured, Cricetulus, Female, Cricetinae, Humans, Male, Microscopy, Fluorescence, Middle Aged, Peptide Fragments, Immunoblotting, Biomarkers, Interleukin-6, Amyloid beta-Peptides, CHO Cells, Cellular Senescence, Cyclin-Dependent Kinase Inhibitor p16, Matrix Metalloproteinase 1, p38 Mitogen-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.